日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Multi-omics unveils BCAA metabolism markers L-leucine and HMGCS1 as prognostic marker for immunotherapy efficacy in non-small cell lung cancer.

多组学揭示 BCAA 代谢标志物 L-亮氨酸和 HMGCS1 可作为非小细胞肺癌免疫疗法疗效的预后标志物

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-025-03277-8
Dai Liyuan, Wang Xinzheng, Lou Ning, Li Lin, Huang Liling, Tang Le, Yao Jiarui, Shi Yuankai, Han Xiaohong
代谢
肺癌
发表日期：2025
文献求助 收藏

Early and high-volume administration of sodium bicarbonate in sepsis-associated acute kidney injury in patients with malignancies, during continuous renal replacement therapy

在接受连续性肾脏替代治疗的恶性肿瘤患者中，脓毒症相关急性肾损伤早期大剂量应用碳酸氢钠

期刊:Renal Failure
影响因子:3
doi:10.1080/0886022X.2024.2443026
Ouyang, Lamei; Pan, Yin; Wu, Ya-Fei; Tang, Qiang; Wang, Dao-Feng; Lou, Ning
肿瘤
肿瘤免疫
炎症/感染
败血症
肾损伤
毒理研究
发表日期：2025
文献求助 收藏

Low-dose loop diuretics improve survival and renal function in cancer patients with early-stage sepsis-associated acute kidney injury

低剂量袢利尿剂可改善早期脓毒症相关急性肾损伤癌症患者的生存率和肾功能

期刊:Renal Failure
影响因子:3
doi:10.1080/0886022X.2025.2560604
Tang, Qiang; Pan, Yin; Niu, Yu-Bo; Wu, Ya-Fei; Wang, Dao-Feng; Lou, Ning
肿瘤
肿瘤免疫
炎症/感染
败血症
肾损伤
毒理研究
发表日期：2025
文献求助 收藏

Pre-existing Anti-AAV9 antibodies in the Chinese healthy and rare disease populations: Implications for gene therapy

中国健康人群和罕见病人群中预先存在的抗AAV9抗体：对基因治疗的启示

期刊:Virus Research
影响因子:2.7
doi:10.1016/j.virusres.2025.199549
Zhao, Qian; Yu, Shuangqing; Fu, Diyi; Wu, Zhen; Zhou, Jianfang; Yang, Yi; Chen, Chen; Wu, Ni; Wang, Yucan; Xi, Wanlin; Lou, Ning; Wu, Xiaobing; Han, Xiaohong
基因治疗
发表日期：2025
文献求助 收藏

Mutational variant allele frequency profile as a biomarker of response to immune checkpoint blockade in non-small cell lung Cancer

突变变异等位基因频率谱作为非小细胞肺癌免疫检查点阻断治疗反应的生物标志物

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-024-05400-7
Gao, Ruyun; Lou, Ning; Li, Lin; Xie, Tongji; Xing, Puyuan; Tang, Le; Yao, Jiarui; Han, Xiaohong; Shi, Yuankai
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

对接受第三代 EGFR-TKI 治疗的 EGFR 突变型非小细胞肺癌患者进行血浆代谢组学分析

期刊:Scientific Data
影响因子:6.9
doi:10.1038/s41597-024-04169-0
Lou, Ning; Gao, Ruyun; Shi, Yuankai; Han, Xiaohong
肺癌
肿瘤
肿瘤免疫
EGF
代谢
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic data

利用电子病历和药代动力学数据，开发并验证基于深度学习的模型，以预测早期临床试验中T790M突变型非小细胞肺癌患者的疗效和生存期。

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-23-737
Lou, Ning; Cui, Xinge; Lin, Xinyuan; Gao, Ruyun; Xu, Chi; Qiao, Nan; Jiang, Ji; Wang, Lu; Wang, Weicong; Wang, Shanbo; Shen, Wei; Zheng, Xin; Han, Xiaohong
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Prognostic Value and Immunological Role of POP7 in Clear Cell Renal Cell Carcinoma

POP7在透明细胞肾细胞癌中的预后价值和免疫学作用

期刊:Pharmacogenomics & Personalized Medicine
影响因子:1.8
doi:10.2147/PGPM.S469247
Lou, Ning; Meng, Xiangui; Yu, Tiexi; Li, Weiquan; Lv, Xin; Han, Weiwei; Xiao, Wen; Shi, Ying
肿瘤
肿瘤免疫
肾癌
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC

对批量和单细胞RNA测序数据的整合分析发现，癌症相关成纤维细胞特征可作为非小细胞肺癌免疫治疗的预后因素。

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-023-03428-0
Wang, Shasha; Fan, Guangyu; Li, Lin; He, Yajun; Lou, Ning; Xie, Tongji; Dai, Liyuan; Gao, Ruyun; Yang, Mengwei; Shi, Yuankai; Han, Xiaohong
肺癌
成纤维细胞
肿瘤
肿瘤免疫
单细胞
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays

利用高通量蛋白芯片技术鉴定中国前列腺癌患者血清中新型自身抗体

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-022-03242-0
Lou, Ning; Zheng, Cuiling; Wang, Yanrong; Liang, Caixia; Tan, Qiaoyun; Luo, Rongrong; Zhang, Lei; Xie, Tongji; Shi, Yuankai; Han, Xiaohong
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏